Gerhard Koenig

Advisor at Atlas Venture, Inc.

Gerhard Koenig

Gerhard Koenig

Advisor at Atlas Venture, Inc.

Overview
Career Highlights

Quartet Medicine, Inc.

RelSci Relationships

670

Number of Boards

2

Birthday

1966

Age

55

Relationships
RelSci Relationships are individuals Gerhard Koenig likely has professional access to. A relationship does not necessarily indicate a personal connection.

President, Treasurer & Director at Q32 Bio, Inc.

Relationship likelihood: Strong

Co-Founder at Disarm Therapeutics, Inc.

Relationship likelihood: Strong

Member, Adjunct Faculty at The Trudeau Institute

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director at Keystone Symposia

Relationship likelihood: Strong

Co-Founder at Rodin Therapeutics, Inc.

Relationship likelihood: Strong

Chief Scientific Officer at Surface Oncology, Inc.

Relationship likelihood: Strong

Executive Chairman at Catamaran Bio, Inc.

Relationship likelihood: Strong

Director & Chief Scientific Officer at Keystone Symposia

Relationship likelihood: Strong

Professional at Bayer AG

Relationship likelihood: Strong

Partner at Merck Research Ventures

Relationship likelihood: Strong

Paths to Gerhard Koenig
Potential Connections via
Relationship Science
You
Gerhard Koenig
Advisor at Atlas Venture, Inc.
Education

Heidelberg University sees itself as a research university with a strong international orientation. Besides enhancing its disciplinary strengths, the University places special emphasis on maintaining the dialogue across traditional subject boundaries. Heidelberg University has twelve faculties with a total of more than 30,000 students and a research and teaching staff of more than 5,000 scientists - among them 450 professors. Numerous great minds have learned, taught and conducted research at Heidelberg University. The oldest German university has thus played an important part in shaping science and society since its founding in 1386. The University is at the centre of a research network that includes a large number of non-university research institutions and companies in Heidelberg and the Rhine-Neckar region.

Career History
Advisor
Current

Atlas Venture focuses on investments in early-stage companies operating in the fields of biotechnology. The firm partners with entrepreneurs to build companies around innovative science.

President & Chief Executive Officer
2016 - Prior

Quartet Medicine, Inc. is a biotechnology company that develops treatments for chronic pain and inflammation by restoring tetrahydrobiopterin homeostasis inneuronal and inflammatory cells. Its drug discovery efforts are fully structurally enabled and are focused on demonstrating changes in BH4-related biomarkers that correlate with drug pharmacokinetics and efficacy in preclinical animal models. The company was founded by Kevin Pojasek, Kai Johnsson, and Clifford Woolf in 2013 and is headquartered in Cambridge, MA.

Chief Scientific Officer & Senior Vice President-Research
2003 - Prior

FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gerhard Koenig. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gerhard Koenig's profile does not indicate a business or promotional relationship of any kind between RelSci and Gerhard Koenig.